COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 87 filers reported holding COGENT BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $318,572 | -14.1% | 32,674 | +4.4% | 0.00% | – |
| Q2 2023 | $370,723 | +24.4% | 31,311 | +13.4% | 0.00% | – |
| Q1 2023 | $297,955 | +46.3% | 27,614 | +56.8% | 0.00% | – |
| Q4 2022 | $203,630 | -97.0% | 17,615 | -96.1% | 0.00% | -100.0% |
| Q3 2022 | $6,825,000 | -15.3% | 457,483 | -48.8% | 0.00% | 0.0% |
| Q2 2022 | $8,060,000 | +8660.9% | 893,592 | +7189.9% | 0.00% | – |
| Q1 2022 | $92,000 | -9.8% | 12,258 | +3.9% | 0.00% | – |
| Q4 2021 | $102,000 | 0.0% | 11,799 | -2.8% | 0.00% | – |
| Q3 2021 | $102,000 | -98.3% | 12,135 | -98.3% | 0.00% | -100.0% |
| Q2 2021 | $5,919,000 | -4.1% | 729,846 | +3.8% | 0.00% | -50.0% |
| Q1 2021 | $6,173,000 | -21.5% | 703,084 | +0.4% | 0.00% | 0.0% |
| Q4 2020 | $7,861,000 | – | 700,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 1,558,975 | $17,507,000 | 6.26% |
| COMMODORE CAPITAL LP | 760,025 | $8,535,000 | 4.64% |
| Ally Bridge Group (NY) LLC | 1,622,591 | $18,222,000 | 3.12% |
| Ghost Tree Capital, LLC | 1,100,000 | $12,353,000 | 2.75% |
| Logos Global Management LP | 1,920,500 | $21,567,000 | 1.85% |
| Altium Capital Management LP | 432,563 | $4,858,000 | 1.81% |
| VR Adviser, LLC | 1,088,817 | $12,227,000 | 1.80% |
| Atlas Venture Associates IX, LLC | 916,196 | $10,289,000 | 1.63% |
| Atlas Venture Associates XI, LLC | 916,196 | $10,289,000 | 1.63% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 235,066 | $2,640,000 | 1.53% |